677
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression of mast cell tryptase and immunoglobulin E is increased in cutaneous photodamage: implications for carcinogenesis

, , , &
Article: 2307488 | Received 08 Sep 2023, Accepted 15 Jan 2024, Published online: 30 Jan 2024

References

  • Leiter U, Keim U, Garbe K. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol. 2020;1268:1–9. doi: 10.1007/978-3-030-46227-7_6.
  • Matsumura Y, Ananthaswamy HN. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev Mol Med. 2002;4(26):1–22. doi: 10.1017/S146239940200532X.
  • Kochevar IE. Molecular and cellular effects of UV radiation relevant to chronic photodamage. In: Gilchrest BA, editor. Photodamage. New York: Blackwell Scientific Publishers; 1995. p. 51–58.
  • Lavker RM, Gerberick GF, Veres D, et al. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol. 1995;32(1):53–62. doi: 10.1016/0190-9622(95)90184-1.
  • Harvima IT, Nilsson G, Suttle M-M, et al. Is there a role for mast cells in psoriasis? Arch Dermatol Res. 2008;300(9):461–478. doi: 10.1007/s00403-008-0874-x.
  • Schechter NM, Irani AM, Sprows JL, et al. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol. 1990;145(8):2652–2661. doi: 10.4049/jimmunol.145.8.2652.
  • Irani AM, Bradford TR, Kepley CL, et al. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37(10):1509–1515. doi: 10.1177/37.10.2674273.
  • Ch’ng S, Wallis RA, Yuan L, et al. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19(1):149–159. doi: 10.1038/modpathol.3800474.
  • Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol. 2011;91(6):644–650. doi: 10.2340/00015555-1197.
  • Ribatti D, Tamma R, Crivellato E. The dual role of mast cells in tumor fate. Cancer Lett. 2018;433(433):252–258. doi: 10.1016/j.canlet.2018.07.005.
  • Wille JJ, Kydonieus AF, Murphy GF. Cis-urocanic acid induces mast cell degranulation and release of preformed TNF-alpha: a possible mechanism linking UVB and cis-urocanic acid to immunosuppression of contact hypersensitivity. Skin Pharmacol Appl Skin Physiol. 1999;12(1-2):18–27. doi: 10.1159/000029842.
  • Grimbaldeston MA, Skov L, Finlay-Jones JJ, et al. Increased dermal mast cell prevalence and susceptibility to development of basal cell carcinoma in humans. Methods. 2002;28(1):90–96. doi: 10.1016/s1046-2023(02)00213-x.
  • Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Sunlight, immunosuppression, and skin cancer: role of histamine and mast cells. Clin Exp Pharmacol Physiol. 2001;28(1-2):1–8. doi: 10.1046/j.1440-1681.2001.03392.x.
  • Siiskonen H, Smorodchenko A, Krause K, et al. Ultraviolet radiation and skin mast cells: effects, mechanisms and relevance for skin diseases. Exp Dermatol. 2018;27(1):3–8. doi: 10.1111/exd.13402.
  • Harvima RJ, Harvima IT, Dull D, et al. Identification and characterization of multiple forms of tryptase from human mast cells. Arch Dermatol Res. 1999;291(2-3):73–80. doi: 10.1007/s004030050386.
  • Kaminska R, Helisalmi P, Harvima RJ, et al. Focal dermal–epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase. J Invest Dermatol. 1999;113(4):567–573. doi: 10.1046/j.1523-1747.1999.00738.x.
  • Huttunen M, Harvima IT. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol. 2005;152(6):1149–1160. doi: 10.1111/j.1365-2133.2005.06428.x.
  • Iddamalgoda A, Le QT, Ito K, et al. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res. 2008;300 Suppl 1(S1):S69–S76. doi: 10.1007/s00403-007-0806-1.
  • Bosset S, Bonnet-Duquennoy M, Barré P, et al. Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities. Br J Dermatol. 2003;149(4):826–835. doi: 10.1046/j.1365-2133.2003.05456.x.
  • Komulainen J, Siiskonen H, Harvima IT. Association of elevated serum tryptase with cutaneous photodamage and skin cancers. Int Arch Allergy Immunol. 2021;182(11):1135–1142. doi: 10.1159/000517287.
  • Sutton BJ, Davies AM, Bax HJ, et al. IgE antibodies: from structure to function and clinical translation. Antibodies. 2019;8(1):19. doi: 10.3390/antib8010019.
  • Bieber T. The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (Fc epsilon RI). Immunobiology. 2007;212(6):499–503. doi: 10.1016/j.imbio.2007.03.001.
  • Barata LT, Ying S, Grant JA, et al. Allergen-induced recruitment of Fc&RI + eosinophils in human atopic skin. Eur J Immunol. 1997;27(5):1236–1241. doi: 10.1002/eji.1830270527.
  • Komulainen J, Siiskonen H, Haimakainen S, et al. Patients with a history of atopy have fewer cutaneous melanomas and malignancies in extracutaneous sites than those without atopy: a study in 496 patients at risk of skin cancers. Melanoma Res. 2023;33(3):218–229. doi: 10.1097/CMR.0000000000000887.
  • Wiemels JL, Wiencke JK, Li Z, et al. Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2377–2383. doi: 10.1158/1055-9965.EPI-11-0668.
  • Crawford G, Hayes MD, Seoane RC, et al. Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response. Nat Immunol. 2018;19(8):859–870. doi: 10.1038/s41590-018-0161-8.
  • Weller KN, McDonnell JC, Albert JM, et al. Increased hazard risk of first malignancy in adults with undetectable serum IgE: a retrospective cohort study. J Clin Immunol. 2023;43(3):568–577. doi: 10.1007/s10875-022-01401-7.
  • Ferastraoaru D, Jordakieva G, Jensen-Jarolim E. The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence. World Allergy Organ J. 2021;14(1):100505. doi: 10.1016/j.waojou.2020.100505.
  • Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients–where do we stand today? Am J Transplant. 2008;8(11):2192–2198. doi: 10.1111/j.1600-6143.2008.02386.x.
  • Harvima IT, Naukkarinen A, Harvima RJ, et al. Immunoperoxidase and enzymehistochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res. 1988;280(6):363–370. doi: 10.1007/BF00426615.
  • Siiskonen H, Poukka M, Bykachev A, et al. Low numbers of tryptase + and chymase + mast cells associated with reduced survival and advanced tumor stage in melanoma. Melanoma Res. 2015;25(6):479–485. doi: 10.1097/CMR.0000000000000192.
  • Kaukinen A, Fitzgibbon A, Oikarinen A, et al. Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers. Dermatology. 2014;229(4):353–358. doi: 10.1159/000365189.
  • Gruber BL, Marchese MJ, Suzuki K, et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest. 1989;84(5):1657–1662. doi: 10.1172/JCI114344.
  • Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99(11):2691–2700. doi: 10.1172/JCI119458.
  • Abe M, Kurosawa M, Ishikawa O, et al. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy. 1998;28(12):1509–1517. doi: 10.1046/j.1365-2222.1998.00360.x.
  • Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 1997;99(6):1313–1321. doi: 10.1172/JCI119290.
  • Weber A, Knop J, Maurer M. Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol. 2003;148(2):224–228. doi: 10.1046/j.1365-2133.2003.05090.x.
  • Ortiz A, Grando SA. Smoking and skin. Int J Dermatol. 2012;51(3):250–262. doi: 10.1111/j.1365-4632.2011.05205.x.
  • Taggart C, Cervantes-Laurean D, Kim G, et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem. 2000;275(35):27258–27265. doi: 10.1074/jbc.M004850200.
  • Schechter NM, Sprows JL, Schoenberger OL, et al. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem. 1989;264(35):21308–21315. doi: 10.1016/S0021-9258(19)30080-8.
  • Diaconu N-C, Kaminska R, Naukkarinen A, et al. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. J Eur Acad Dermatol Venereol. 2007;21(7):908–915. doi: 10.1111/j.1468-3083.2006.02100.x.
  • Biswas A, Richards JE, Massaro J, et al. Mast cells in cutaneous tumors: innocent bystander or maestro conductor? Int J Dermatol. 2014;53(7):806–811. doi: 10.1111/j.1365-4632.2012.05745.x.
  • Grimbaldeston MA, Skov L, Finlay-Jones JJ, et al. Squamous cell carcinoma is not associated with high dermal mast cell prevalence in humans. J Invest Dermatol. 2002;119(5):1204–1206. doi: 10.1046/j.1523-1747.2002.19511.x.
  • Grimbaldeston MA, Pearce AL, Robertson BO, et al. Association between melanoma and dermal mast cell prevalence in sun-unexposed skin. Br J Dermatol. 2004;150(5):895–903. doi: 10.1111/j.1365-2133.2004.05966.x.
  • Wulaningsih W, Holmberg L, Garmo H, et al. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival. Oncoimmunology. 2016;5(6):e1154250. doi: 10.1080/2162402X.2016.1154250.
  • Hayes M, Ward S, Crawford G, et al. Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth. Elife. 2020;9:e51862. doi: 10.7554/eLife.51862.
  • Chauhan J, Grandits M, Palhares LCGF, et al. Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4. Nat Commun. 2023;14(1):2192. doi: 10.1038/s41467-023-37811-3.
  • Spicer J, Basu B, Montes A, et al. Safety and anti-tumor activity of the IgE antibody MOv18 in patients with advanced solid tumors expressing folate receptor-alpha: a phase I trial. Nat Commun. 2023;14(1):4180. doi: 10.1038/s41467-023-39679-9.
  • Nakamura M, Souri EA, Osborn G, et al. IgE activates monocytes from cancer patients to acquire a pro-inflammatory phenotype. Cancers. 2020;12(11):3376. doi: 10.3390/cancers12113376.